We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Guidance on Bioequivalence Studies, Presubmission Correspondence
FDA Offers Guidance on Bioequivalence Studies, Presubmission Correspondence
Sponsors hoping to use equivalence criteria in analyzing bioequivalence (BE) studies for their drug applications just got more details on how the FDA wants them to undertake that.